These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 23327522)

  • 1. Toward a universal influenza virus vaccine: prospects and challenges.
    Pica N; Palese P
    Annu Rev Med; 2013; 64():189-202. PubMed ID: 23327522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New vaccines against influenza virus.
    Lee YT; Kim KH; Ko EJ; Lee YN; Kim MC; Kwon YM; Tang Y; Cho MK; Lee YJ; Kang SM
    Clin Exp Vaccine Res; 2014 Jan; 3(1):12-28. PubMed ID: 24427759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pandemic preparedness: toward a universal influenza vaccine.
    Roose K; Fiers W; Saelens X
    Drug News Perspect; 2009 Mar; 22(2):80-92. PubMed ID: 19330167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the development of influenza virus vaccines.
    Krammer F; Palese P
    Nat Rev Drug Discov; 2015 Mar; 14(3):167-82. PubMed ID: 25722244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal influenza vaccines: Shifting to better vaccines.
    Berlanda Scorza F; Tsvetnitsky V; Donnelly JJ
    Vaccine; 2016 Jun; 34(26):2926-2933. PubMed ID: 27038130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research progress and prospect of universal influenza vaccine].
    Luo DY; Xue CY; Cao YC
    Bing Du Xue Bao; 2013 Nov; 29(6):646-50. PubMed ID: 24520771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Universal influenza vaccines, a dream to be realized soon.
    Zhang H; Wang L; Compans RW; Wang BZ
    Viruses; 2014 Apr; 6(5):1974-91. PubMed ID: 24784572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursor.
    Bianchi E; Liang X; Ingallinella P; Finotto M; Chastain MA; Fan J; Fu TM; Song HC; Horton MS; Freed DC; Manger W; Wen E; Shi L; Ionescu R; Price C; Wenger M; Emini EA; Cortese R; Ciliberto G; Shiver JW; Pessi A
    J Virol; 2005 Jun; 79(12):7380-8. PubMed ID: 15919893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances, Approaches and Challenges in the Development of Universal Influenza Vaccines.
    Lim CML; Komarasamy TV; Adnan NAAB; Radhakrishnan AK; Balasubramaniam VRMT
    Influenza Other Respir Viruses; 2024 Mar; 18(3):e13276. PubMed ID: 38513364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progress in new vaccine strategies against influenza: a review].
    Liu Z; Jiang T; Qin E; Ran D; Qin C
    Sheng Wu Gong Cheng Xue Bao; 2012 May; 28(5):550-6. PubMed ID: 22916493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects for universal influenza virus vaccine.
    Gerhard W; Mozdzanowska K; Zharikova D
    Emerg Infect Dis; 2006 Apr; 12(4):569-74. PubMed ID: 16704803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes.
    Pushko P; Pearce MB; Ahmad A; Tretyakova I; Smith G; Belser JA; Tumpey TM
    Vaccine; 2011 Aug; 29(35):5911-8. PubMed ID: 21723354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine approaches conferring cross-protection against influenza viruses.
    Vemula SV; Sayedahmed EE; Sambhara S; Mittal SK
    Expert Rev Vaccines; 2017 Nov; 16(11):1141-1154. PubMed ID: 28925296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant vaccines for influenza virus.
    Tripp RA; Tompkins SM
    Curr Opin Investig Drugs; 2008 Aug; 9(8):836-45. PubMed ID: 18666031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. M2e-based universal influenza A vaccine.
    Fiers W; De Filette M; El Bakkouri K; Schepens B; Roose K; Schotsaert M; Birkett A; Saelens X
    Vaccine; 2009 Oct; 27(45):6280-3. PubMed ID: 19840661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pandemic influenza vaccines: from the lab to ethical policy making].
    Grotto I; Levine H; Balicer RD
    Harefuah; 2009 Oct; 148(10):672-6, 735. PubMed ID: 20073393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
    Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
    Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection.
    O'Hagan DT
    Expert Rev Vaccines; 2007 Oct; 6(5):699-710. PubMed ID: 17931151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influenza season 1998/99; composition of vaccine for 1999/2000].
    Rimmelzwaan GF; de Jong JC; Bartelds AI; Dorigo-Zetsma JW; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 1999 Oct; 143(40):2015-8. PubMed ID: 10535060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza-specific antibody-dependent cellular cytotoxicity: toward a universal influenza vaccine.
    Jegaskanda S; Reading PC; Kent SJ
    J Immunol; 2014 Jul; 193(2):469-75. PubMed ID: 24994909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.